Annual CFO:
$118.67M+$109.87M(+1248.55%)Summary
- As of today, ADMA annual cash from operations is $118.67 million, with the most recent change of +$109.87 million (+1248.55%) on December 31, 2024.
- During the last 3 years, ADMA annual cash from operations has risen by +$231.04 million (+205.61%).
- ADMA annual cash from operations is now at all-time high.
Performance
ADMA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$21.14M+$40.81M(+207.44%)Summary
- As of today, ADMA quarterly cash from operations is $21.14 million, with the most recent change of +$40.81 million (+207.44%) on June 30, 2025.
- Over the past year, ADMA quarterly cash from operations has dropped by -$24.51 million (-53.69%).
- ADMA quarterly cash from operations is now -57.90% below its all-time high of $50.22 million, reached on December 31, 2024.
Performance
ADMA Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$76.71M-$24.51M(-24.21%)Summary
- As of today, ADMA TTM cash from operations is $76.71 million, with the most recent change of -$24.51 million (-24.21%) on June 30, 2025.
- Over the past year, ADMA TTM cash from operations has increased by +$3.70 million (+5.07%).
- ADMA TTM cash from operations is now -35.36% below its all-time high of $118.67 million, reached on December 31, 2024.
Performance
ADMA TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ADMA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +1248.5% | -53.7% | +5.1% |
| 3Y3 Years | +205.6% | +264.8% | +189.5% |
| 5Y5 Years | +255.8% | +199.3% | +185.8% |
ADMA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +205.6% | -57.9% | +207.4% | -35.4% | +189.6% |
| 5Y | 5-Year | at high | +205.6% | -57.9% | +163.2% | -35.4% | +163.1% |
| All-Time | All-Time | at high | +205.6% | -57.9% | +163.2% | -35.4% | +163.1% |
ADMA Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $21.14M(+207.4%) | $76.71M(-24.2%) |
| Mar 2025 | - | -$19.68M(-139.2%) | $101.22M(-14.7%) |
| Dec 2024 | $118.67M(+1248.5%) | $50.22M(+100.6%) | $118.67M(+37.9%) |
| Sep 2024 | - | $25.03M(-45.2%) | $86.05M(+17.9%) |
| Jun 2024 | - | $45.65M(+2158.0%) | $73.01M(+242.7%) |
| Mar 2024 | - | -$2.22M(-112.6%) | $21.30M(+142.1%) |
| Dec 2023 | $8.80M(+114.8%) | $17.60M(+46.8%) | $8.80M(+154.4%) |
| Sep 2023 | - | $11.99M(+297.8%) | -$16.18M(+61.0%) |
| Jun 2023 | - | -$6.06M(+58.8%) | -$41.45M(+14.0%) |
| Mar 2023 | - | -$14.72M(-99.5%) | -$48.22M(+19.0%) |
| Dec 2022 | -$59.51M(+47.0%) | -$7.38M(+44.5%) | -$59.51M(+30.5%) |
| Sep 2022 | - | -$13.28M(-3.5%) | -$85.59M(+0.1%) |
| Jun 2022 | - | -$12.83M(+50.7%) | -$85.72M(+18.5%) |
| Mar 2022 | - | -$26.01M(+22.3%) | -$105.15M(+6.4%) |
| Dec 2021 | -$112.37M(-10.2%) | -$33.47M(-149.5%) | -$112.37M(-1.1%) |
| Sep 2021 | - | -$13.41M(+58.4%) | -$111.12M(+8.6%) |
| Jun 2021 | - | -$32.26M(+2.9%) | -$121.56M(-9.9%) |
| Mar 2021 | - | -$33.23M(-3.1%) | -$110.59M(-8.4%) |
| Dec 2020 | -$102.00M(-33.9%) | -$32.22M(-35.1%) | -$102.00M(-14.1%) |
| Sep 2020 | - | -$23.85M(-12.1%) | -$89.44M(-0.2%) |
| Jun 2020 | - | -$21.28M(+13.6%) | -$89.21M(-3.1%) |
| Mar 2020 | - | -$24.65M(-25.4%) | -$86.55M(-13.6%) |
| Dec 2019 | -$76.19M(-21.6%) | -$19.65M(+16.8%) | -$76.19M(-1.1%) |
| Sep 2019 | - | -$23.63M(-26.9%) | -$75.33M(-17.3%) |
| Jun 2019 | - | -$18.62M(-30.4%) | -$64.25M(-6.1%) |
| Mar 2019 | - | -$14.29M(+24.0%) | -$60.53M(+3.4%) |
| Dec 2018 | -$62.68M | -$18.79M(-49.8%) | -$62.68M(-9.5%) |
| Sep 2018 | - | -$12.54M(+15.9%) | -$57.24M(-5.2%) |
| Jun 2018 | - | -$14.91M(+9.3%) | -$54.44M(-12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$16.43M(-23.0%) | -$48.31M(-29.6%) |
| Dec 2017 | -$37.27M(-104.0%) | -$13.36M(-37.2%) | -$37.27M(-35.4%) |
| Sep 2017 | - | -$9.74M(-11.0%) | -$27.53M(-22.5%) |
| Jun 2017 | - | -$8.78M(-62.6%) | -$22.47M(-21.5%) |
| Mar 2017 | - | -$5.40M(-49.4%) | -$18.50M(-1.3%) |
| Dec 2016 | -$18.27M(-18.5%) | -$3.61M(+22.8%) | -$18.27M(+2.5%) |
| Sep 2016 | - | -$4.68M(+2.5%) | -$18.73M(-12.0%) |
| Jun 2016 | - | -$4.80M(+7.0%) | -$16.72M(-2.2%) |
| Mar 2016 | - | -$5.17M(-26.7%) | -$16.37M(-6.1%) |
| Dec 2015 | -$15.42M(-4.9%) | -$4.08M(-52.6%) | -$15.42M(-8.3%) |
| Sep 2015 | - | -$2.67M(+39.9%) | -$14.24M(-1.5%) |
| Jun 2015 | - | -$4.45M(-5.3%) | -$14.04M(-1.1%) |
| Mar 2015 | - | -$4.22M(-45.4%) | -$13.89M(+5.6%) |
| Dec 2014 | -$14.70M(-35.1%) | -$2.90M(-17.7%) | -$14.70M(+0.4%) |
| Sep 2014 | - | -$2.47M(+42.6%) | -$14.76M(-1.7%) |
| Jun 2014 | - | -$4.30M(+14.8%) | -$14.52M(-13.0%) |
| Mar 2014 | - | -$5.04M(-70.3%) | -$12.85M(-18.1%) |
| Dec 2013 | -$10.89M(-57.7%) | -$2.96M(-33.0%) | -$10.89M(-11.8%) |
| Sep 2013 | - | -$2.23M(+15.3%) | -$9.73M(-1.3%) |
| Jun 2013 | - | -$2.63M(+14.6%) | -$9.61M(-20.4%) |
| Mar 2013 | - | -$3.07M(-70.2%) | -$7.98M(-15.6%) |
| Dec 2012 | -$6.90M(-382.4%) | -$1.81M(+14.0%) | -$6.90M(-35.5%) |
| Sep 2012 | - | -$2.10M(-110.8%) | -$5.10M(-70.1%) |
| Jun 2012 | - | -$996.90K(+50.1%) | -$3.00M(-49.9%) |
| Mar 2012 | - | -$2.00M(>-9900.0%) | -$2.00M(-9283.6%) |
| Dec 2011 | -$1.43M(+70.3%) | - | - |
| Mar 2011 | - | -$3900.00(+56.7%) | -$21.30K(-22.4%) |
| Dec 2010 | -$4.81M(>-9900.0%) | -$9000.00(-7.1%) | -$17.40K(-107.1%) |
| Sep 2010 | - | -$8400.00 | -$8400.00 |
| Jun 2010 | -$19.70K | - | - |
FAQ
- What is ADMA Biologics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. annual cash from operations year-on-year change?
- What is ADMA Biologics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. quarterly cash from operations year-on-year change?
- What is ADMA Biologics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. TTM cash from operations year-on-year change?
What is ADMA Biologics, Inc. annual cash from operations?
The current annual cash from operations of ADMA is $118.67M
What is the all-time high annual cash from operations for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high annual cash from operations is $118.67M
What is ADMA Biologics, Inc. annual cash from operations year-on-year change?
Over the past year, ADMA annual cash from operations has changed by +$109.87M (+1248.55%)
What is ADMA Biologics, Inc. quarterly cash from operations?
The current quarterly cash from operations of ADMA is $21.14M
What is the all-time high quarterly cash from operations for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high quarterly cash from operations is $50.22M
What is ADMA Biologics, Inc. quarterly cash from operations year-on-year change?
Over the past year, ADMA quarterly cash from operations has changed by -$24.51M (-53.69%)
What is ADMA Biologics, Inc. TTM cash from operations?
The current TTM cash from operations of ADMA is $76.71M
What is the all-time high TTM cash from operations for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high TTM cash from operations is $118.67M
What is ADMA Biologics, Inc. TTM cash from operations year-on-year change?
Over the past year, ADMA TTM cash from operations has changed by +$3.70M (+5.07%)